Karachi: Citi Pharma Ltd has disclosed a noteworthy transaction involving its Executive Director, Izwan Ahmad, who has executed a substantial purchase of company shares. The transaction was reported under the Pakistan Stock Exchange (PSX) Regulation 5.6.4, which mandates the disclosure of interests held by directors, executives, and their close associates.

According to the company’s notification dated February 26, 2026, Izwan Ahmad, in his capacity as an Executive Director, acquired 200,000 shares in the market. This transaction took place on February 23, 2026, and was executed through the Central Depository Company (CDC) in the ready market. The shares were purchased at a rate of approximately 85.005198 per share.

The cumulative number of shares held by Izwan Ahmad now stands at 22.75%. According to information available from the Pakistan Stock Exchange (PSX), this acquisition represents a very large or significant move in terms of percentage change in his shareholding position.

Citi Pharma Ltd, operating within the designated market category of pharmaceuticals, continues to observe compliance with PSX regulations by ensuring transparency and timely disclosure of such transactions. The company’s actions reflect adherence to governance standards crucial for stakeholders and investors.